KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Pacific Biosciences Of California (PACB) Leases (2017 - 2025)

Pacific Biosciences Of California has reported Leases over the past 8 years, most recently at $41.7 million for Q4 2025.

  • Quarterly results put Leases at $41.7 million for Q4 2025, up 159.12% from a year ago — trailing twelve months through Dec 2025 was $41.7 million (up 159.12% YoY), and the annual figure for FY2025 was $41.7 million, up 159.12%.
  • Leases for Q4 2025 was $41.7 million at Pacific Biosciences Of California, down from $42.6 million in the prior quarter.
  • Over the last five years, Leases for PACB hit a ceiling of $46.6 million in Q4 2021 and a floor of $16.1 million in Q4 2024.
  • Median Leases over the past 5 years was $37.3 million (2023), compared with a mean of $34.6 million.
  • Biggest five-year swings in Leases: plummeted 50.63% in 2024 and later skyrocketed 159.12% in 2025.
  • Pacific Biosciences Of California's Leases stood at $46.6 million in 2021, then fell by 14.7% to $39.8 million in 2022, then decreased by 18.03% to $32.6 million in 2023, then plummeted by 50.63% to $16.1 million in 2024, then skyrocketed by 159.12% to $41.7 million in 2025.
  • The last three reported values for Leases were $41.7 million (Q4 2025), $42.6 million (Q3 2025), and $43.5 million (Q2 2025) per Business Quant data.